Page 44 - Read Online
P. 44

Yapali et al. Hepatoma Res 2018;4:24  I  http://dx.doi.org/10.20517/2394-5079.2018.57                                               Page 3 of 10

               Table 2. Etiology of HCC in Eastern Mediterranean countries
                Location               Alcohol           HBV               HCV             Other
                Afghanistan            11%               36%               32%             21%
                Bahrain                17%               39%               28%             16%
                Cyprus                 32%               19%               39%             14%
                Dijibouti              13%               33%               36%             18%
                Egypt                  12%               13%               63%             12%
                Iran                   6%                44%               24%             26%
                Iraq                   12%               37%               32%             19%
                Israel                 15%               20%               49%             17%
                Jordan                 15%               35%               31%             19%
                Kuwait                 15%               37%               31%             18%
                Lebanon                17%               28%               40%             15%
                Libya                  15%               33%               34%             18%
                Morocco                14%               31%               36%             19%
                Oman                   17%               39%               28%             16%
                Pakistan               7%                16%               54%             23%
                Qatar                  18%               38%               28%             15%
                Saudi Arabia           17%               41%               17%             25%
                Somalia                15%               36%               30%             18%
                Sudan                  18%               35%               30%             16%
                Syria                  14%               32%               34%             19%
                Tunisia                18%               20%               44%             18%
                Turkey                 19%               26%               44%             11%
                United Arab Emirates   21%               44%               22%             13%
                Yemen                  8%                44%               35%             12%
                               [8]
               Adapted from reference . HCC: hepatocellular carcinoma; HBV: hepatitis B virus; HCV: hepatitis C virus

               RISK FACTORS FOR HCC
               The major risk factors for HCC are the presence of cirrhosis, and HBV/HCV infection. Other factors, such as
               aflatoxin B exposure and nonalcoholic steatohepatitis (NASH) are important in certain regions of the world.
               In the high-incidence countries of Asia and Africa, chronic HBV infection and aflatoxin B exposure are the
               major risk factors. Exceptionally, in Japan and Egypt the most common risk factor is HCV infection. On
               the contrary, excessive alcohol consumption and metabolic syndrome play more important roles in the low-
               incidence regions. In addition, inherited metabolic disorders such as hemochromatosis, A1AT deficiency,
               tyrosinemia, several porphyrias also increase the risk of HCC .
                                                                   [13]

               The distribution of viral and other risk factors of HCC in the Eastern Mediterranean countries are
               summarized in Table 2.


               Chronic hepatitis B
               Countries with HBV prevalence of greater than 2% have increased incidence and mortality rates of HCC.
               The majority (70%-90%) of HBV-related HCC develops in patients with cirrhosis [14,15] . In persons chronically
               infected with HBV, the risk of HCC has been shown to increase up to 30-fold [14,15] . As a result of hepatic
               inflammation and liver damage, genetic and epigenetic defects lead to development of HCC [16-18] . However, in
               the absence of cirrhosis HCC can develop in 10%-20% of HBV-infected individuals as a result of integration
               of HBV into the host genome that induces chromosomal alterations and insertional mutagenesis of cancer
               genes [17-19] . The genetic instability of the hepatocyte triggers the clonal growth of hepatocytes before the
               liver damage occurs. HBV-encoded X protein (HBx) which is a multifunctional protein that regulates the
               expression of genes in the involved in the signal cascades, has a pivotal role in the pathogenesis of HBV-
               related HCC [17-19] . In addition to cirrhosis, other factors reported to increase HCC risk among patients with
               chronic HBV comprise; demographic (male sex, older age, Asian or African ancestry, family history of HCC),
               viral [higher levels of HBV replication, HBeAg positivity, HBV genotype, longer duration of infection, co-
   39   40   41   42   43   44   45   46   47   48   49